Editorial Board ::: Infectious Disorders - Drug Targets

ISSN: 2212-3989 (Online)
ISSN: 1871-5265 (Print)


Volume 16, 3 Issues, 2016


Download PDF Flyer




Infectious Disorders - Drug Targets

Formerly: Current Drug Targets - Infectious Disorders

This journal supports open access

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Jean-Marc Sabatier
Laboratoire ERT 62 'Ingénierie des peptides à visée thérapeutique'
Université de la Méditerranée
Faculté de Médecine Nord
Boulevard Pierre Dramard
13916 - MARSEILLE, Cedex 20
France


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Editorial Board

Editor-in-Chief:

Jean-Marc Sabatier (Biography
Jean-Marc Sabatier

Jean-Marc SABATIER is a Director of research at the French CNRS, with PhD and HDR degrees in Biochemistry and Microbiology. He headed several academic research teams (CNRS, INSERM and University), as well as a combined academic-industry research laboratory devoted to the engineering of therapeutic peptides (ERT62, Marseilles, France). He was also a Director of Research for several French private companies as well as a Canadian public company. He acts as a Consultant for top pharmaceutical and cosmetic companies. Dr. Sabatier works in the field of animal toxins. He so far contributed to several books in toxinology and virology, and more than 160 scientific articles, 180 communications, and 53 patents in both biology and chemistry.

)

Laboratoire ERT 62 'Ingénierie des peptides à visée thérapeutique'
Université de la Méditerranée
Faculté de Médecine Nord
Boulevard Pierre Dramard
13916 - MARSEILLE, Cedex 20
France



Co-Editor(s):

Zhijan Cao (Biography
Zhijan Cao

Dr. Cao is a professor from College of Life Sciences, Wuhan University, China. He has nearly 20 years of experience in the research of animal toxin peptides, involving in cDNA, genome, biological and pharmacological roles (such as anti-virus, anti-tumor, ion-channel-modulating), molecular diversity and evolution. Dr. Cao graduated Ph.D from College of Life Sciences, Wuhan University, China in 2004. He was a visiting scholar of Meharry Medical College, USA from 2014 to 2015. Notably, Dr. Cao has authored more than 100 manuscripts and 12 patents. He was an Excellent Young Scholar of China National Science Fund in 2014 and got Youth Science and Technology Award from Chinese Society of Toxicology in 2016.

)

Visiting scholar
Meharry Medical Collage
USA


Founding Editor(s):

Robert Goldman
RGC Consulting
Wimauma, FL
USA


Associate Editor(s):

Tommy R. Tong (Biography
Tommy R. Tong

Prof. Tong obtained his medical degrees (M.B.,B.S., MD) from the University of Hong Kong and the University of the State of New York. He has also American Board of Pathology-certified and fellowship-trained at Memorial Sloan Kettering Cancer Center. Currently, he is Clinical Professor of Pathology at City of Hope Comprehensive Cancer Center. He has published multiple peer-reviewed scientific articles, owns 4 U.S. patents and named co-inventor in a pending U.S. patent application. He is on the editorial board of multiple journals, as well as associate editor of this journal, published by Bentham Science Publishers.

)

Department of Pathology, Montefiori Medical Center
Bronx, NY
USA

M. Tumbarello
Catholic University of the Sacred Heart
Rome
Italy


Regional Editor(s):

A.R. Amin
Virginia College of Osteopathic Medicine (VCOM)
VA
USA

Z. Cao
University of Wuhan
P.R.
China

I. Qadri
King Abdul Aziz University
Jeddah
Saudi Arabia


Section Editor(s):

(Microbiology)
T.A. Black
Infectious Diseases, Merck Research Laboratories
Kenilworth, NJ
USA

(Virology, HIV)
E. Loret
Lab. Retrovirology, Faculté de Pharmacie
Marseille Cedex 5
France

(Microbiology)
Prof. Jinglin Wang
The Laboratory of Toxinology
Beijing Institute of Microbiology and Epidemiology
Beijing
China

(Microbiology)
L.E. Hensley
US Army Medical Research Institute of Infectious Diseases
Maryland
USA

(Virology, SARS)
T.R. Tong
Dep. Path. Montefiori Med. Center North Div.
Bronx, NY
USA


Editorial Board Members:

Hourieh ALKADI
Faculty of Science
Damascus University Damascus
Syria

D. Andreotti (Biography
D. Andreotti

Dr. D. Andreotti obtained his degree in Chemistry from the University of Ferrara, Italy, in addition Dr. Andreotti also holds a further qualification as Specialist in Organic Synthesis from University of Milan, Italy. Dr. Andreotti has got about 30 years of experience in the Drug Discovery field with a particular focus on the antibacterial side. He has published more than 65 scientific publications including papers and patents. Since 2015 Dr. Andreotti is member of the Editorial Board Member of IDDT journal.

)

GlaxoSmithkline Res. Centre
Verona
Italy

Jean-Claude Chermann
URRMA R&D, Centre de Vie Agora
Aubagne Cedex
France

E.De. Clercq
Rega Institute for Medical Research,KU
Leuven
Belgium

F. Doucet-Populaire
University of Paris
Paris
France

R. Gallo
University of Maryland in Baltimore
Maryland
USA

S. Ilyin
Johnson & Johnson Pharm Res and Dev.
Spring House, PA
USA

W. Liu
Wuhan University
Wuhan
China

R.N. Ondarza (Biography
R.N. Ondarza

Professor of Biochemistry, Faculty of Medicine, Universidad Nacional Autonoma de Mexico,UNAM and Medical Researcher, Center of Research on Infectious Diseases, National Institute of Public Health Doctor in Biology (Biochemistry) Faculty of Sciences , UNAM, 1963. Fellow John Simon Guggenheim Memorial Foundation, 1963 Doctor Honoris causa, Universite du Paris Xlll, Republique Francaise, Ministere de l'Education Nationale, Academie de Creteil, 1984. Visiting Professor in four occasions, at Scripps Institution of Oceanography, University of California, San Diego at La Jolla, California, during his sabbatical years, 1964, 1982, 2002, 2005 and Visiting Researcher, Department of Chemistry, University of California, San Diego, at La Jolla, 1986. 50 scientific publications and 16 books.

)

Nat. Institute Public Health
Mexico

F. Scaglione
University of Milan
Milan
Italy

M.J. Sofia
Pharmasset, Incorporation
Princeton, NJ
USA

M. Wainberg
McGill AIDS Centre, Jewish General Hospital
Montreal
Canada

Q. Zhao
Yale University School of Medicine
New Haven
USA

C. Abad-Zapatero
Abbott Lab.
Abbott Park, IL
USA

A. Branstrom
PTC Therapeutics
South Plainfield, NJ
USA

S. Chinikar
National Reference Laboratory
Tehran
Iran

H.L. Davis
Coley Pharm. Group,Ottawa
Ontario, ON
Canada

B.M. Dunn (Biography
B.M. Dunn

Distinguished Professor Ben M. Dunn received his Ph.D. in Chemistry from the University of California at Santa Barbara in 1971 and did postdoctoral work at the National Institutes of Health from 1971-1974. He joined the Department of Biochemistry and Molecular Biology in 1974 and moved through the ranks to his current title. He served as President of the American Peptide Society from 2011-2013 and was President of the International Proteolysis Society. He is the Editor-in-Chief of two Bentham journals, Protein and Peptide Letters, for research reports and mini-reviews, and Current Protein and Peptide Science, which publishes exclusively review papers.

)

University of Florida College of Medicine
Florida
USA

O. Golubnitschaja
Friedrich-Wilhelms, University of Bonn
Germany

K-T. Jeang
Nat. Institute Health
Bethesda, MD
USA

H. Maltezou
Hellenic Center for Disease Control and Prevention
Athens
Greece

I. Qadri
King Abdul Aziz University
Jeddah
Saudi Arabia

M.E. Selsted
Keck School of Medicine of USC
Los Angeles
USA

G.G. Stone
Pfizer Global Research and Development
Groton
USA

T. Wood (Biography
T. Wood

Tony leads Worldwide Research & Development’s Medicinal Sciences, a group that encompasses the small molecule and large molecule partner lines that enable and accelerate Pfizer’s end-to-end portfolio to deliver medicines and vaccines to patients.Prior to this appointment,Tony served as the the head of Worldwide Medicinal Chemistry. Tony also served as Head of Chemistry and Exploratory Medicinal Sciences in Sandwich from February 2007 and Head of Chemistry from April 2004. Tony joined Pfizer as a Scientist in the Department of Discovery Chemistry at Sandwich in 1992. Over the period of the next 8 years he made a number of contributions to the delivery of development candidates in various projects from within the Sexual Health, Urology, and Gastrointestinal Therapeutic Areas.

)

Pfizer Global Research and Development
Kent
UK

A. A. Y. Abouelfetouh
Alexandria University
Alexandria
Egypt

Y. Cheng
Yale University
New Haven, CT
USA

P. Clapham
University of Massachusetts Medical School
Worcester, MA
USA

N.D. Djadid
Pasteur Institute of Iran
Tehran
Iran

B. Finlay
University British Colombia
Vancouver, BC
Canada

G. Gregoriadis
University London
London
UK

D. Kahne
Harvard University
Boston, MA, NJ
USA

M.C. O'Sullivan
Canisius College
Buffulo, NY
USA

F. Roohvand
Pasteur Institute of Iran
Tehran
Iran

I. Shinkai
Mitsui & Co. Ltd.
Tokyo
Japan

B. L. Tekwani
National Center for Natural Products Research
University of Mississippi
USA

Z. Xiao-Lian (Biography
Z. Xiao-Lian

Dr. Zhang received a master degree of Virology and Molecular Biology (1986) from Wuhan University and Ph.D degree of Biochemistry (1997) from Hongkong University of Science and Technology. She did her postdoctoral training at Univ. of Maryland, College Park, MD, USA.

Now Dr. Zhang is chairman of Immunology Department, Director of Hubei Province Key Laboratory of Allergy and Immunology,“Luojia” distinguished professor of Wuhan University, Professor of State Key Laboratory of Virology at Wuhan University, China.

Dr. Zhang has long been focused on the research of infection immunology of intracellular pathogens. She discovered type IV pili gene operon and site-specific recombination enzyme gene on Salmonella typhi pathogen virulence island. She also found some key functions of glycan and glycosylation during pathogens (Hepatitis C Virus, Mycobacterium Tuberculosis) infection.

)

Department of Immunology, Wuhan University
China


Advertisement

Related Journals




Related eBooks


Webmaster Contact: urooj@benthamscience.org Copyright © 2016 Bentham Science